Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Christelle Tychyj"'
Autor:
Danny-Joe Fiani, Jean-François Émile, Luc Istier, Anne-Blandine Boutin, Christelle Tychyj, Nazim Benzerdjeb, Marie Donzel, Brigitte Balme, Alexandra Traverse-Glehen, Juliette Fontaine
Publikováno v:
Annales de Pathologie. 42:475-480
Autor:
Danny-Joe, Fiani, Jean-François, Émile, Luc, Istier, Anne-Blandine, Boutin, Christelle, Tychyj, Nazim, Benzerdjeb, Marie, Donzel, Brigitte, Balme, Alexandra, Traverse-Glehen, Juliette, Fontaine
Publikováno v:
Annales de pathologie. 42(6)
Rosai-Dorfman-Destombes disease is a rare non-Langerhansian cell histiocytosis characterized by the accumulation of large activated histiocytes in the affected tissues with images of emperipolesis. The diagnosis is not really problematic in the class
Autor:
E. Decullier, F. Réty, P.J. Valette, Gilles Salles, Francesco Giammarile, I. Orliaguet, A.F. Manichon, F. Chateau, F. Ricard, Anne-Sophie Michallet, C. Houzard, Christelle Tychyj-Pinel
Publikováno v:
Journal de Radiologie Diagnostique et Interventionnelle. 95:59-66
Resume Introduction Le but est de determiner comment l’interpretation conjuguee du scanner diagnostique et de la TEP-TDM peut ameliorer le bilan morphologique en onco-hematologie. Patients et methodes Cinquante-neuf patients atteints de lymphome ag
Autor:
F. Réty, C. Houzard, Anne-Sophie Michallet, Gilles Salles, Francesco Giammarile, F. Ricard, F. Chateau, P.J. Valette, E. Decullier, Christelle Tychyj-Pinel, A.F. Manichon, I. Orliaguet
Publikováno v:
Diagnostic and Interventional Imaging. 95:55-62
Our goal was to determine how interpreting diagnostic CT together with PET-CT could improve the assessment of morphology in onco-haematology.Fifty-nine patients with aggressive lymphoma were retrospectively included. The diagnostic CT scan was interp
Autor:
Hervé Tilly, Rene-Olivier Casasnovas, Luc Xerri, Jehan Dupuis, Alina Berriolo-Riedinger, Gaetano Paone, Nathalie Berenger, Pierre Soubeyran, Gilles Salles, Philippe Colombat, Pierre Feugier, Andrea Gallamini, Pauline Brice, Christelle Tychyj-Pinel, Anne Julian, Corinne Haioun, Pierre Vera, Michel Meignan, Guy Laurent, Nicolas Mounier
Publikováno v:
Journal of Clinical Oncology. 30:4317-4322
Purpose [18F]Fluorodeoxyglucose positron emission tomography (PET) is widely used for the staging and restaging of patients with aggressive lymphoma, but less is known about the utility of PET in patients with follicular lymphoma (FL). In a prospecti
Autor:
Michael J. Conte, Gilles Salles, Jeremy Tordot, Christelle Tychyj-Pinel, Pierre Sesques, Fabien Subtil, Emmanuel Itti, Kari G. Rabe, Jehan Dupuis, Lucile Baseggio, Anne-Sophie Michallet
Publikováno v:
Leukemia & lymphoma
Leukemia & lymphoma, Taylor & Francis, 2016, 57, pp.1474--1477. ⟨10.3109/10428194.2015.1099643⟩
Leukemia & lymphoma, Taylor & Francis, 2015, 57 (6), pp.1474-1477. ⟨10.3109/10428194.2015.1099643⟩
Leukemia & lymphoma, 2015, 57 (6), pp.1474-1477. ⟨10.3109/10428194.2015.1099643⟩
Leukemia & lymphoma, 2016, 57, pp.1474--1477. 〈10.3109/10428194.2015.1099643〉
Leukemia & lymphoma, Taylor & Francis, 2016, 57, pp.1474--1477. ⟨10.3109/10428194.2015.1099643⟩
Leukemia & lymphoma, Taylor & Francis, 2015, 57 (6), pp.1474-1477. ⟨10.3109/10428194.2015.1099643⟩
Leukemia & lymphoma, 2015, 57 (6), pp.1474-1477. ⟨10.3109/10428194.2015.1099643⟩
Leukemia & lymphoma, 2016, 57, pp.1474--1477. 〈10.3109/10428194.2015.1099643〉
One of the main CLL complications is Richter syndrome (RS).[1–3] RS develops from the transformation of CLL into an aggressive lymphoma, most commonly diffuse large B-cell lymphoma (DLBCL). RS occu...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24bcbe9d2d15c8deab8e4241a6b12936
https://hal.archives-ouvertes.fr/hal-01812690
https://hal.archives-ouvertes.fr/hal-01812690
Autor:
Michael J. Fulham, Pierre Vera, Gilles Salles, Thierry Lamy, Christelle Tychyj-Pinel, Michel Meignan, F. Ricard, Judith Trotman, Marion Fournier
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging
European Journal of Nuclear Medicine and Molecular Imaging, Springer Verlag (Germany), 2014, 41 (3), pp.408-15
European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 (3), pp.408-15
European Journal of Nuclear Medicine and Molecular Imaging, Springer Verlag (Germany), 2014, 41 (3), pp.408-15
European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 (3), pp.408-15
International audience; We aimed to compare the standardized central review of (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/CT scans performed after induction therapy for follicular lymphoma (FL) in the PRIMA study (Salles et al.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2443afa6ed14e5d91ebf92ed62ebb7f
https://hal.archives-ouvertes.fr/hal-01141154
https://hal.archives-ouvertes.fr/hal-01141154
Autor:
Pierre Payoux, Elisabeth Miot-Noirault, Florence Granel-Brocard, Micheline Razzouk-Cadet, Françoise Gachon, Fathalah Benbouzid, Charles Merlin, Christelle Tychyj, V. Isnardi, Caroline Gaudy, Jean-Philippe Lacour, Florent Cachin, Antony Kelly, Bruno Labeille, D. Mestas, Françoise Degoul, Nicolas Meyer, Françoise Baulieu, M. D’Incan, Jean Daniel Grange, Brigitte Gillet, Jean-Michel Chezal, Serge Cammilleri
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 55(1)
Our group has developed a new radiopharmaceutical, (123)I - N-(2-diethylaminoethyl)-2-iodobenzamide ((123)I-BZA2), a benzamide derivative able to bind to melanin pigment in melanoma cells. In a prospective and multicentric phase III clinical study, t
Autor:
Gilles G Salles, Christelle Tychyj-Pinel, Françoise Berger, Deborah Bauwens, Laure Lebras, Fadhela Bouafia-Sauvy, Anne-Sophie Michallet, Bertrand Coiffier, Anne A D'Hombres
Publikováno v:
Journal of Hematology & Oncology
Journal of Hematology and Oncology, Vol. 6, no. 1, p. 45 [1-7] (2013)
Journal of Hematology and Oncology, Vol. 6, no. 1, p. 45 [1-7] (2013)
Background: Less than 20% of patients with follicular lymphoma (FL) present with Ann Arbor Stage I or II disease at diagnosis. Numerous therapeutic options exist, however radiation therapy is considered the standard of care for early-stage disease ba
Publikováno v:
Current opinion in oncology. 22(5)
Purpose of review This article reviews the role of interim fluorine-18-fluorodeoxyglucose (FDG)-PET in the management of aggressive non-Hodgkin lymphoma. Recent findings In the diagnosis of diffuse large B-cell lymphoma, FDG-PET has proved to be a hi